Chrome Holding Co.
DelistedCIK 1804591fmd_1Y393R51AP73JCJ0082PEW40WWManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Apr 01, 2019 to Jun 30, 2025, 22 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Total revenues | 305 | 244 | 272 | 299 | 220 | 190 |
| Cost of revenue | 168 | 127 | 139 | 167 | 122 | 90 |
| Net interest income | 6 | 0 | 0 | 10 | 14 | – |
| Gross profit | 137 | 117 | 133 | 132 | 98 | 100 |
| Research and development | 181 | 160 | 189 | 116 | 105 | 102 |
| Selling, general and administrative | 170 | 142 | 198 | 239 | 218 | 178 |
| Total operating expenses | 396 | 302 | 387 | 355 | 680 | 341 |
| Operating income | (258) | (185) | (254) | (223) | (582) | (241) |
| Other non-operating income (expense) | 1 | 1 | (0) | (0) | 1 | 1 |
| Income before taxes | (251) | (184) | (221) | (314) | (667) | – |
| Income tax expense | 0 | 0 | (3) | (3) | 0 | (0) |
| Net income from continuing operations | (251) | (184) | (217) | (211) | (567) | (235) |
| Net income | (251) | (184) | (217) | (312) | (667) | (281) |